Anti-TNR25/ TNFRSF12/ TNFRSF25 monoclonal antibody

Anti-TNR25/ TNFRSF12/ TNFRSF25 antibody for FACS & in-vivo assay

Target products collectionGo to TNFRSF12/TNFRSF25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IO142-Ab-1/ GM-Tg-hg-IO142-Ab-2Anti-Human TNFRSF12/TNFRSF25 monoclonal antibodyHuman
GM-Tg-rg-IO142-Ab-1/ GM-Tg-rg-IO142-Ab-2Anti-Rat TNFRSF12/TNFRSF25 monoclonal antibodyRat
GM-Tg-mg-IO142-Ab-1/ GM-Tg-mg-IO142-Ab-2Anti-Mouse TNFRSF12/TNFRSF25 monoclonal antibodyMouse
GM-Tg-cynog-IO142-Ab-1/ GM-Tg-cynog-IO142-Ab-2Anti-Cynomolgus/ Rhesus macaque TNFRSF12/TNFRSF25 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IO142-Ab-1/ GM-Tg-felg-IO142-Ab-2Anti-Feline TNFRSF12/TNFRSF25 monoclonal antibodyFeline
GM-Tg-cang-IO142-Ab-1/ GM-Tg-cang-IO142-Ab-2Anti-Canine TNFRSF12/TNFRSF25 monoclonal antibodyCanine
GM-Tg-bovg-IO142-Ab-1/ GM-Tg-bovg-IO142-Ab-2Anti-Bovine TNFRSF12/TNFRSF25 monoclonal antibodyBovine
GM-Tg-equg-IO142-Ab-1/ GM-Tg-equg-IO142-Ab-2Anti-Equine TNFRSF12/TNFRSF25 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IO142-Ab-1/ GM-Tg-hg-IO142-Ab-2; GM-Tg-rg-IO142-Ab-1/ GM-Tg-rg-IO142-Ab-2;
GM-Tg-mg-IO142-Ab-1/ GM-Tg-mg-IO142-Ab-2; GM-Tg-cynog-IO142-Ab-1/ GM-Tg-cynog-IO142-Ab-2;
GM-Tg-felg-IO142-Ab-1/ GM-Tg-felg-IO142-Ab-2; GM-Tg-cang-IO142-Ab-1/ GM-Tg-cang-IO142-Ab-2;
GM-Tg-bovg-IO142-Ab-1/ GM-Tg-bovg-IO142-Ab-2; GM-Tg-equg-IO142-Ab-1/ GM-Tg-equg-IO142-Ab-2
Products NameAnti-TNFRSF12/TNFRSF25 monoclonal antibody
Formatmab
Target NameTNFRSF12
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TNFRSF12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TNR25/ TNFRSF12/ TNFRSF25 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-IO142-Ag-1tumor necrosis factor receptor superfamily, member 25 (TNFRSF25) protein
    ORF Viral VectorpGMLPm005126mouse Tnfrsf25 Lentivirus plasmid
    ORF Viral VectorvGMLPm005126mouse Tnfrsf25 Lentivirus particle


    Target information

    Target IDGM-IO142
    Target NameTNFRSF12
    Gene ID8718,85030,500592,703744,489632,101090784,783432,100059424
    Gene Symbol and SynonymsAPO-3,DDR3,DR3,GEF720,LARD,PLEKHG5,TNFRSF12,TNFRSF25,TR3,TRAMP,Wsl,WSL-1,WSL-LR
    Uniprot AccessionQ93038
    Uniprot Entry NameTNR25_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseLung Cancer
    Gene EnsemblENSG00000215788
    Target ClassificationCheckpoint-Immuno Oncology

    The target: TNFRSF12, gene name: TNFRSF25, also named as APO-3, DDR3, DR3, GEF720, LARD, PLEKHG5, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.